Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy.
about
Downregulation of Hlx closely related to the decreased expressions of T-bet and Runx3 in patients with gastric cancer may be associated with a pathological event leading to the imbalance of Th1/Th2.Cloning and expression of feline colony stimulating factor receptor (CSF-1R) and analysis of the species specificity of stimulation by colony stimulating factor-1 (CSF-1) and interleukin-34 (IL-34)Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy.Correction: Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapyAssessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells?
P2860
Granulocyte-macrophage stimulating factor (GM-CSF) increases circulating dendritic cells but does not abrogate suppression of adaptive cellular immunity in patients with metastatic colorectal cancer receiving chemotherapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Granulocyte-macrophage stimula ...... cancer receiving chemotherapy.
@en
type
label
Granulocyte-macrophage stimula ...... cancer receiving chemotherapy.
@en
prefLabel
Granulocyte-macrophage stimula ...... cancer receiving chemotherapy.
@en
P2093
P2860
P356
P1476
Granulocyte-macrophage stimula ...... cancer receiving chemotherapy.
@en
P2093
Kestutis Planutis
Marina Planutiene
Micaela Martinez
Randall F Holcombe
P2860
P2888
P356
10.1186/1475-2867-12-2
P577
2012-01-23T00:00:00Z
P5875
P6179
1024652857